Evaluation of the Role of PlGF and the Therapeutic Potential of Anti-PlGF in BCR/ABL+ Leukemia.
Sonja Loges(German Cancer Research Center), Peter Carmeliet(Khalifa University of Science and Technology), Jan Cools(KU Leuven), Christa Maes(KU Leuven), Geert Carmeliet(KU Leuven), Kim De Keersmaecker(VIB-KU Leuven Center for Cancer Biology), Thomas Schmidt(Paul Scherrer Institute), Marc Tjwa, Christiane Dewolf-Peeters(KU Leuven), Maria Kleppe(Memorial Sloan Kettering Cancer Center), Jean–Marie Stassen(Boehringer Ingelheim (Germany))
Cited by 0
Related Papers
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
|Nature|1996|4.2k
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
|Cancer Cell|2005|3k